Duncan Mc Hale Evelo Biosciences, Inc. (EVLO) insider trading activity
Duncan Mc Hale is Chief Medical Officer of Evelo Biosciences, Inc.. Currently has a direct ownership of 16,984 shares of EVLO, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 3,103 shares (Common Stock) at a price of $0.33 per share, resulting in proceeds of $1,023. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
17K
0%
3M change
25.0%
12M change
Total Value Held
$0
Duncan McHale Transaction History
DM
Duncan Mc Hale
Chief Medical Officer
Cambridge, MA